U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 06:51:11 GMT 2025
Edited
by admin
on Wed Apr 02 06:51:11 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG4|KAPPA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
3QW12I37H1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Surovatamig
INN  
Official Name English
AZD-0486
Preferred Name English
AZD0486
Code English
surovatamig [INN]
Common Name English
immunoglobulin (H-gamma4_L-kappa)_VH-G4(h-CH2-CH3), anti-[Homo sapiens CD3D (CD3 delta) and CD3E (CD3 epsilon, Leu-4) dimer] and anti-[Homo sapiens CD19 (B lymphocyte surface antigen B4, Leu-12)], Homo sapiens and humanized monoclonal antibody asymetric,
Common Name English
H-gamma4 heavy chain anti-CD3D/CD3E dimer, Homo sapiens (1-450) [VH (Homo sapiens IGHV3-9*01 (100%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.16] (26-33.51-58.97-112)) (1-123)-Homo sapiens IGHG4*01 nG4m(a) CH2 L92, G4v5 h P10, G4v4 CH2 A1.3, A1.2, G4v32 CH
Common Name English
TNB-486
Code English
Immunoglobulin G4 [231-proline,237-alanine,238-alanine,369-tryptophan], bispecific, anti-(human CD3 antigen) (human monoclonal AZD0486 ?4-chain) disulfide with human monoclonal AZD0486 ?-chain, (229?124?),(232?127?)-bis(disulfide) with immunoglobulin [12
Common Name English
Code System Code Type Description
NCI_THESAURUS
C178577
Created by admin on Wed Apr 02 06:51:11 GMT 2025 , Edited by admin on Wed Apr 02 06:51:11 GMT 2025
PRIMARY
FDA UNII
3QW12I37H1
Created by admin on Wed Apr 02 06:51:11 GMT 2025 , Edited by admin on Wed Apr 02 06:51:11 GMT 2025
PRIMARY
INN
13199
Created by admin on Wed Apr 02 06:51:11 GMT 2025 , Edited by admin on Wed Apr 02 06:51:11 GMT 2025
PRIMARY
CAS
2892667-02-4
Created by admin on Wed Apr 02 06:51:11 GMT 2025 , Edited by admin on Wed Apr 02 06:51:11 GMT 2025
PRIMARY
SMS_ID
300000048298
Created by admin on Wed Apr 02 06:51:11 GMT 2025 , Edited by admin on Wed Apr 02 06:51:11 GMT 2025
PRIMARY
From To
3_134 3_194
3_23 3_88
2_265 2_323
2_22 2_96
1_370 1_428
1_264 1_324
1_232 2_127
1_229 2_124
1_137 3_214
1_150 1_206
1_22 1_96
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
Related Record Type Details
TARGET->WEAK AGONIST
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL